Moderna Inks 25M COVID-19 Shots Supply Pact With Australia

by Vandana Singh, Benzinga Editor

May 12, 2021 8:05 AM | 29 seconds read | Make a Comment

Moderna Inc MRNA has announced a new agreement to supply 25 million doses of its COVID-19 vaccine to Australia.
The deal includes 10 million doses of the company's mRNA-1273 vaccine delivered this year and 15 million doses of its variant booster vaccine candidate to be delivered in 2022.
The agreement is subject to the approval of mRNA-1273 and the booster vaccine candidate by Australia's Therapeutic Goods Administration.
Price Action: MRNA shares are down 0.75% at $157.84 during the premarket session on the last check Wednesday.

Posted In: Biotech Government News Health Care Contracts General Australia Briefs COVID-19 Vaccine

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.